What the Pharmaceutical Industry Can Learn from Peloton about Patient Retention and Engagement
June 26, 2019 - HIT Leaders
Today’s mostly paper-dependent clinical trials pose fundamental challenges to the pharmaceutical industry. Such trials can be prohibitively expensive, struggle to enroll and retain a sufficient number of participants, and have difficulty maintaining compliance and data reliability. But with the advent of virtual and partially virtual trials using digital tools and devices, we have the opportunity to substantially improve efficiency by deploying the same design principles that make consumer apps so successful.
Recent News:
HIT Leaders: What the Pharmaceutical Industry Can Learn from Peloton about Patient Retention and Engagement
Today’s mostly paper-dependent clinical trials pose fundamental challenges to the pharmaceutical industry. Such trials can be prohibitively expensive, struggle to enroll and retain a sufficient number of participants, and have difficulty maintaining compliance and data reliability. But with the advent of virtual and partially virtual trials using digital tools and devices, we have the opportunity to substantially improve efficiency by deploying the same design principles that make consumer apps so successful.
Today’s mostly paper-dependent clinical trials pose fundamental challenges to the pharmaceutical industry. Such trials can be prohibitively expensive, struggle to enroll and retain a sufficient number of participants, and have difficulty maintaining compliance and data reliability. But with the advent of virtual and partially virtual trials using digital tools and devices, we have the opportunity to substantially improve efficiency by deploying the same design principles that make consumer apps so successful.
June 26, 2019
MMM Online: Humanizing the health experience
How close are we to personalizing healthcare? This was the theme of MM&M and Deloitte Digital’s aptly named event, Humanizing the Health Experience, which took place at Deloitte Digital’s downtown NYC offices earlier this month.
How close are we to personalizing healthcare? This was the theme of MM&M and Deloitte Digital’s aptly named event, Humanizing the Health Experience, which took place at Deloitte Digital’s downtown NYC offices earlier this month.
June 25, 2019
ACRP Net: Alzheimer’s Studies Adopt ‘Bring Your Own Device’ Strategy for Participants
Scientists with the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University in St. Louis School of Medicine are undertaking five years of studies of a rare form of early-onset Alzheimer’s disease using a “bring your own device” (BYOD) study model.
Scientists with the Dominantly Inherited Alzheimer Network (DIAN) at the Washington University in St. Louis School of Medicine are undertaking five years of studies of a rare form of early-onset Alzheimer’s disease using a “bring your own device” (BYOD) study model.
June 25, 2019
HIT Consultant: Washington University Alzheimer’s Study Adopts BYOD Technology for Clinical Trials & Observational Study
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.
The Washington University School of Medicine in Saint Louis has selected Datacubed Health’s mobile platform has been selected to support worldwide studies for those at risk of Dominantly Inherited Alzheimer’s Disease, a rare form of early-onset Alzheimer’s Disease. The Linkt platform enables the collection of real-time data on sleep, diet and other biomarkers using a “bring your own device” (BYOD) study model.
June 21, 2019
mHealth Intelligence : Alzheimer’s Research Study to Use mHealth for Remote Monitoring
The Washington University School of Medicine in St. Louis is launching a five-year study that will use an mHealth app and connected health platform to monitor people living with Dominantly Inherited Alzheimer's Disease.
The Washington University School of Medicine in St. Louis is launching a five-year study that will use an mHealth app and connected health platform to monitor people living with Dominantly Inherited Alzheimer's Disease.
June 19, 2019
MedCity News: Leveraging technology and digital tools to (finally) increase diversity in clinical trials
If used mindfully, the latest advances in technology could create a more comfortable environment in which we can begin to bring in underrepresented populations and reverse the lack of diversity in clinical trials.
If used mindfully, the latest advances in technology could create a more comfortable environment in which we can begin to bring in underrepresented populations and reverse the lack of diversity in clinical trials.
April 25, 2019
Pharmaphorum: Study will gauge impact of smartphone on memory and focus
Scientists are to use an app to conduct the first crowdsourcing study on the impact of smartphone use on working memory, mental focus and attention.
Scientists are to use an app to conduct the first crowdsourcing study on the impact of smartphone use on working memory, mental focus and attention.
March 15, 2019
The Hill: Unleash the full potential of the Human Genome Project
With the advent of large-scale databases that measure everything from credit-worthiness (a strong predictor of overall health), to individual social networks (a predictor of mental health), to air quality (a predictor of asthma), comprehensive pheno-typing is becoming practical.
With the advent of large-scale databases that measure everything from credit-worthiness (a strong predictor of overall health), to individual social networks (a predictor of mental health), to air quality (a predictor of asthma), comprehensive pheno-typing is becoming practical.
March 14, 2019
Clinical Research News: Bring-Your-Own-Device In Clinical Trials: Achieving High Quality Data At Lower Cost
Surveys now suggest that half of all companies in North America allow bring-your-own-device (BYOD), recognizing the security capabilities of current smart devices as well as the reduced costs, higher performance, compliance rates and ease of managing a single phone.
Surveys now suggest that half of all companies in North America allow bring-your-own-device (BYOD), recognizing the security capabilities of current smart devices as well as the reduced costs, higher performance, compliance rates and ease of managing a single phone.
February 21, 2019
Outsourcing Pharma: ‘The magic balance’: Diverse advisory boards guide clinical trial design
'Biopharma has a real opportunity to move quickly with remote, virtual trial technology,' says Data Cubed's new CCO
'Biopharma has a real opportunity to move quickly with remote, virtual trial technology,' says Data Cubed's new CCO
February 20, 2019
Outsourcing Pharma: Will advances in digital health be driven by a combination of Silicon Valley know-how and clinical trial expertise?
It will take a marriage between Silicon Valley and clinical trials expertise to drive innovation in the digital health space, which is being held back by uncertainty – and a reluctance that is keeping industry executives up at night.
It will take a marriage between Silicon Valley and clinical trials expertise to drive innovation in the digital health space, which is being held back by uncertainty – and a reluctance that is keeping industry executives up at night.
February 12, 2019
PM360: PM360 2018 Innovative Product Data Cubed
Since its founding in 2016, Data Cubed has helped to lead the next-generation of mHealth data capture
Since its founding in 2016, Data Cubed has helped to lead the next-generation of mHealth data capture
December 18, 2018
Outsourcing Pharma: Data Cubed looks to be the go-to provider as the industry shifts to virtual clinical trials
'Biopharma has a real opportunity to move quickly with remote, virtual trial technology,' says Data Cubed's new CCO
'Biopharma has a real opportunity to move quickly with remote, virtual trial technology,' says Data Cubed's new CCO
November 7, 2018
Pharma Exec: FDA's $100 Million RWE Project: Making It All It Can Be
In a sign of the increasing role real-world evidence (RWE) will have in healthcare research, FDA recently announced a $100 million proposal to build a modern system to gather RWE from about 10 million individuals. The good news is that this could transform clinical trials for a generation; the bad (or at least worrisome) news is that as currently planned this dramatic initiative might wind up being largely limited to data from electronic health records.
In a sign of the increasing role real-world evidence (RWE) will have in healthcare research, FDA recently announced a $100 million proposal to build a modern system to gather RWE from about 10 million individuals. The good news is that this could transform clinical trials for a generation; the bad (or at least worrisome) news is that as currently planned this dramatic initiative might wind up being largely limited to data from electronic health records.
November 2, 2018
The Association Of Clinical Research Professionals: Gaming Technology Promises Improved Patient Recruitment, Retention
While no one is expecting gamers to line up in droves to “play” in clinical trials, per se, some tech pioneers believe the psychology and design of certain online games can be adapted to improve clinical trial recruitment and retention.
While no one is expecting gamers to line up in droves to “play” in clinical trials, per se, some tech pioneers believe the psychology and design of certain online games can be adapted to improve clinical trial recruitment and retention.
October 23, 2018
Outsourcing Pharma: To focus on the patient, Data Cubed emphasizes design and the ‘lures’ of gaming technology
Taking inspiration from popular games such as Candy Crush and World of Warcraft, Data Cubed has developed a mHealth platform that promises to increase patient engagement in clinical research.
Taking inspiration from popular games such as Candy Crush and World of Warcraft, Data Cubed has developed a mHealth platform that promises to increase patient engagement in clinical research.
September 18, 2018
MedCity News: Startups pitch their solutions to the opioid epidemic at Health 2.0
The $50,000 challenge was sponsered by the Robert Wood Johnson Foundation to help find a tech-enabled approach to addressing substance abuse of opioids.
The $50,000 challenge was sponsered by the Robert Wood Johnson Foundation to help find a tech-enabled approach to addressing substance abuse of opioids.
September 17, 2018
Fast Company: This app enlists friends and family to help fight opioid addiction
ResQ uses a series of games to do psychological assessments, and alerts your support network–friends, family, counselors–if you need help staying clean.
ResQ uses a series of games to do psychological assessments, and alerts your support network–friends, family, counselors–if you need help staying clean.
August 24, 2018
MDDI: Tapping into the World of Gaming to Fight Opioid Addiction
Data Cubed met with Candy Crush and World of Warcraft executives to inform the creation of an app designed to help prevent relapse in people recovering from opioid addiction.
Data Cubed met with Candy Crush and World of Warcraft executives to inform the creation of an app designed to help prevent relapse in people recovering from opioid addiction.
August 23, 2018
Medgadget: ResQ is Using Games to Fight Opioid Addiction: Interview with Dr. Paul Glimcher
Medgadget had a chance to speak with Paul Glimcher, CEO of one of the semifinalists, Data Cubed, developers of the ResQ mobile app. Data Cubed is a life sciences technology company that began as an academic partnership with New York University. The company’s digital health tools highlight the potential for video game technology to achieve high levels of patient engagement leading to better clinical outcomes.
Medgadget had a chance to speak with Paul Glimcher, CEO of one of the semifinalists, Data Cubed, developers of the ResQ mobile app. Data Cubed is a life sciences technology company that began as an academic partnership with New York University. The company’s digital health tools highlight the potential for video game technology to achieve high levels of patient engagement leading to better clinical outcomes.
June 16, 2018
Modern Healthcare: Information Technology: Data Cubed's ResQ app uses video game technology to tackle opioid addiction
Data Cubed is one of five finalists in the Robert Wood Johnson Opioid Challenge, whose winners will be announced in September. In the ResQ app, a user moves an avatar through a city.
Data Cubed is one of five finalists in the Robert Wood Johnson Opioid Challenge, whose winners will be announced in September. In the ResQ app, a user moves an avatar through a city.
May 25, 2018
MedCity News: Data Cubed’s ResQ app uses video game technology to tackle opioid addiction
Data Cubed, a life sciences tech company, has come out with an app called Resilience IQ (or ResQ) that leverages video game technology to help prevent relapse in individuals recovering from opioid addiction.
Data Cubed, a life sciences tech company, has come out with an app called Resilience IQ (or ResQ) that leverages video game technology to help prevent relapse in individuals recovering from opioid addiction.
May 24, 2018
Mobi Health News: Digital health news briefs
Fighting the opioid crisis with social support. Digital health startup Data Cubed was named a semi-finalist in the Robert Wood Johnson Foundation Opioid Challenge for its platform, called the Resilience IQ app.
Fighting the opioid crisis with social support. Digital health startup Data Cubed was named a semi-finalist in the Robert Wood Johnson Foundation Opioid Challenge for its platform, called the Resilience IQ app.
May 15, 2018
PM360: PM Innovators: Startups
Data Cubed (D3) offers the next-generation of mHealth data capture, unlocking the power of clinical trials through real-world evidence. Their cross-platform app and unique hardware solutions allow them to gather a customizable selection of mobile phenomic (social, behavioral, and environmental) data points from instruments—integrating various portable and in-home technologies, customizing patient reported outcomes (ePROs), and implementing eDiaries. In the end, D3’s low-cost solutions yield more actionable data, better insights, and smarter decisions.
Data Cubed (D3) offers the next-generation of mHealth data capture, unlocking the power of clinical trials through real-world evidence. Their cross-platform app and unique hardware solutions allow them to gather a customizable selection of mobile phenomic (social, behavioral, and environmental) data points from instruments—integrating various portable and in-home technologies, customizing patient reported outcomes (ePROs), and implementing eDiaries. In the end, D3’s low-cost solutions yield more actionable data, better insights, and smarter decisions.
December 17, 2017
For media inquiries please contact:
Ulysses Communications
pkerr@ulyssescom.net